MedPath

The effects of Cichorium fatty liver disease

Not Applicable
Conditions
nonalcoholic fatty liver disease.
Other diseases of liver
Registration Number
IRCT20171216037911N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

diagnosis of NAFLD according to ultra-sonography
age between 18 to 65 years
increase SGPT leve more than 30mgr/dl

Exclusion Criteria

Other causes of liver disease, including viral hepatitis or autoimmune, high alcohol consumption (more than 210 g / week in men and more than 140 g / week in women), Wilson's disease, hereditary hemochematosus, alpha1-antitrypsin deficiency and cirrhosis
gestation and lactation;
diagnosis of cancers
consumption of hepatotoxic drugs or drugs using for management of NAFLD
diagnosis of cardiovascular diseases
diagnosis of diabetes mellitus
diagnosis of hypothyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grade of fatty liver. Timepoint: before & 12 weeks after intervention. Method of measurement: liver and bile duct supersonic graphy.;Aspartate aminotransferases. Timepoint: before intervention, 6 weeks after beginning of the intervention, 12 weeks after beginning of the intervention. Method of measurement: blood sample.;Waist circumfrence. Timepoint: before intervention, 6 weeks after beginning of the intervention, 12 weeks after beginning of the intervention. Method of measurement: by using of meter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath